Aspirin's hidden power: new study aims to stop preeclampsia before it starts
NCT ID NCT04295850
First seen Jan 11, 2026 · Last updated Jun 19, 2026 · Updated 18 times
Summary
This study looked at how aspirin works in pregnant women at high risk for preeclampsia, a serious blood pressure disorder. Researchers measured platelet function and genetic factors in 130 women to understand why some still develop the condition. The goal is to personalize aspirin dosing to better prevent preeclampsia in future pregnancies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.